Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
주식 순위 #29361
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
주가
$0.365
마지막 동기화: 2025-08-01
시가총액
$21.54M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Elevation Oncology, Inc. (ELEV)

카테고리

Elevation Oncology, Inc. (ELEV)의 주가 이력
최고 종가: $0.37 (2025-08-01 기준)

최저 종가: $12.36 (2021-06-01 기준)
Elevation Oncology, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2025 -40.93%
2024 21.56%
2023 -47.33%
2022 -81.61%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$542.34 38.79%
US
$1.02K 55.31%
NL
$117.42 -19.34%
AU
$142.63 411.04%
US
$755.10 8.85%
CH